Skip to main content

Innovations for Tackling Tuberculosis in the Time of COVID-19 Proceedings of a Workshop (2022) / Chapter Skim
Currently Skimming:

Appendix C: Workshop Agenda
Pages 167-174

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 167...
... Eric Rubin (New England Journal of Medicine) Challenges and Innovations Moderator: Lucica Ditiu 11:30 AM Diagnostics Soumya Swaminathan (World Health Organization)
Read the entire page →
From page 168...
... 12:55 PM Wrap-up and Adjourn Gail Cassell, workshop co-chair Kenneth Castro, workshop co-chair WORKSHOP -- PART TWO TUESDAY, SEPTEMBER 14, 2021 11:00 AM–2:30 PM ET Workshop Opening 11:00 AM Welcome and Workshop Goals Peter Daszak, Chair, Forum on Microbial Threats, National Academy of Medicine; President, EcoHealth Alliance Lucica Ditiu, moderator, Stop TB Partnership 11:05 AM Sponsor Remarks  Jennifer Adams, Senior Deputy Assistant Administrator, Bureau for Global Health, United States Agency for International Development 11:20 AM Building a Tuberculosis-Free World: Progress Update Eric Goosby (University of California, San Francisco) 15 min Q&A Realities of Multidrug-Resistant TB and Challenges for TB Control Matteo Zignol (World Health Organization)
Read the entire page →
From page 169...
... 1:15 PM Enhancing Adherence, Infection Control Capacities, and Cost-Effectiveness Expansion and Improvements to Contact Tracing and Engagement: Mobile or Digital Platforms from the COVID-19 Pandemic Aamir Khan (IRD) Telehealth and Digital Adherence Technologies Bruce Thomas (The Arcady Group)
Read the entire page →
From page 170...
... 2:15 PM Reflections on Session 1 Lucica Ditiu 2:30 PM Adjourn WORKSHOP PART 2 WEDNESDAY, SEPTEMBER 15, 2021 11:00 AM–2:30 PM ET Session 2: Vaccines and Therapeutics 11:00 AM Welcome and Session Goals Kent Kester, moderator, Sanofi Pasteur 11:05 AM Using Existing Tools and New Technologies BCG Revaccination Alex Schmidt (Bill & Melinda Gates Medical Research Institute) Promising New Adjuvants and Late-Stage Clinical Development Vaccine Candidates Steve Reed (University of Washington; HDT Bio)
Read the entire page →
From page 171...
... 1:00 PM Expert Reflections and Discussion on Critical Elements for Implementation  Ezra Shimeles Tessera (TB Data, Impact Assessment and Communications Hub, USAID; John Snow, Inc.)  Richard Chaisson (Johns Hopkins University School of Medicine and Bloomberg School of Public Health)
Read the entire page →
From page 172...
... 1:05 PM Making the Case for Financing TB Elimination  Margaret Hamburg, moderator, Nuclear Threats Initiative The Cost of Failing to Achieve the End TB Targets: A Full Economic Analysis Michael Reid (University of California, San Francisco) Why TB Is One of the Best Investments on the SDG Agenda Bjorn Lomborg (Copenhagen Consensus Center)
Read the entire page →
From page 173...
... APPENDIX C 173 2:00 PM Closing Remarks Margaret Hamburg Gail Cassell, workshop co-chair Kenneth Castro, workshop co-chair 2:30 PM Adjourn
Read the entire page →

Key Terms

  • lucica ditiu
  • gates medical
  • global health
  • georgetown university
  • pandemic preparedness

  • global commons
  • peter sands
  • gates foundation
  • bold moves
  • kent kester

  • bjorn lomborg
  • using existing
  • existing tools
  • shimeles tessera
  • alex schmidt

  • gail cassell
  • richard chaisson
  • vaccine candidates
  • sanofi pasteur
  • smart investments

  • kenneth castro
  • bloomberg school
  • eric rubin
  • matteo zignol
  • copenhagen consensus

  • senior deputy
  • treatment options
  • development vaccine
  • transforming treatment
  • global development


    • This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
    More information on Chapter Skim is available.